Skip to main content

Featured

Tariff Costs Put New Pressure on U.S. Corporate Profits

Rising tariff expenses are beginning to weigh heavily on U.S. companies, prompting executives across multiple industries to warn that profit margins may tighten in the months ahead. Many firms had initially suggested they could manage the added costs through efficiency improvements or selective price increases, but that confidence is fading as import-related expenses continue to climb. Companies that rely on global supply chains are feeling the strain most acutely. Higher costs on imported materials and components are forcing difficult decisions: pass the increases on to consumers, risking weaker demand, or absorb the costs internally, which directly erodes profitability. For many businesses, neither option is attractive. Consumer-facing brands are finding it especially challenging to raise prices further, as shoppers show growing sensitivity to even modest increases. This resistance limits the ability of firms to offset tariff-driven expenses, creating a squeeze that is beginning t...
Post a Comment
Read more

article

Labels

Drug shortages in Canada affect millions of patients and health care providers

 

  

Many Canadians have experienced the frustration and anxiety of not being able to get the medications they need, as the country faces a persistent and worsening problem of drug shortages.

According to a survey commissioned by the Canadian Pharmacists Association, one in four adults in Canada has either personally been affected by drug shortages in the last three years or knows someone who has. The survey also found that 70% of pharmacists have difficulty finding alternative drugs for their patients.

The causes of drug shortages are complex and varied, ranging from manufacturing issues, supply chain disruptions, regulatory hurdles, market decisions by pharmaceutical companies, and increased demand for certain drugs due to the COVID-19 pandemic.

Some of the drugs that have been in short supply include Lenoltec No. 4, a painkiller containing codeine; Ozempic, a widely-used drug for type 2 diabetes; EpiPens, which are essential for people with life-threatening allergies; Wellbutrin, a popular antidepressant; and various blood pressure medications.

Drug shortages can have serious consequences for patients and health care providers, such as increased costs, reduced quality of care, delayed or cancelled treatments, adverse reactions, medication errors, and psychological distress.

Health Canada has said it is aware of the issue and working to find solutions, such as facilitating the importation of foreign drugs, monitoring the supply situation, and collaborating with stakeholders. However, some experts have called for more action, such as investing in domestic production capacity, creating a national drug agency, and implementing mandatory reporting of drug shortages by manufacturers.

Labels:

Comments

Post a Comment